Company Management

Tvardi Therapeutics

Biotechnology Research Houston, Tx, United States 18 employees

Employees: 18
Contacts: 3
Emails: 3
Phones: 1

tvarditherapeutics.com LinkedIn Crunchbase

Tvardi Therapeutics Overview

Headquarters: Houston, Tx, United States
Phone Number: Available in AeroLeads
Website: tvarditherapeutics.com
Industry: Biotechnology Research
Employees: 18
Founded: 2017
Funding: 72.4M
NAICS: Research and Development in Biotechnology (except Nanobiotechnology)

Keywords

STAT3 Small Molecules Cancer Inflammation Fibrosis

About Tvardi Therapeutics

Tvardi is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. STAT3 is a central mediator across critical fibrotic signaling pathways that drive uncontrolled deposition, proliferation, survival and immune suppression. STAT3 is also positioned at the intersection of many signaling pathways integral to the survival and immune evasion of cancer cells. The company is conducting Phase 2 clinical trials in fibrosis-driven diseases with high unmet need: idiopathic pulmonary fibrosis (NCT05671835) and hepatocellular carcinoma (NCT05440708).

Tvardi Therapeutics Contact Details

People in AeroLeads: 4
With contact data: 3
Email contacts: 3; 75.0% coverage
Phone contacts: 1; 25.0% coverage

Tvardi Therapeutics Org Chart

Sample employees and titles

Name	Title	Location	Contact
Stephen O'brien	Controller - VP of Accounting - Sec	Tomball, Texas, United States	Email Phone
Kevin Vulin	Principal Consultant, Financial	Hartsdale, New York, United States	Email
Sujal Shah	Former President and CEO at Cymabay	San Francisco Bay Area, United States	View
Riley Gaddy, Mba		Raleigh, North Carolina, United States	Email